Santhera Pharmaceuticals Holding Ag Stock Forecast

Buy or Hold candidate since Jun 18, 2026 Gain 1.72%

The Santhera Pharmaceuticals Holding Ag stock price gained 1.72% on the last trading day (Friday, 19th Jun 2026), rising from 15.67 Fr to 15.94 Fr. During the last trading day the stock fluctuated 1.13% from a day low at 15.90 Fr to a day high of 16.08 Fr. The price has fallen in 7 of the last 10 days and is down by -9.33% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 9 thousand more shares were traded than the day before. In total, 13 thousand shares were bought and sold for approximately 201.18 Fr thousand.

The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect Santhera Pharmaceuticals Holding Ag stock with a 90% probability to be traded between 14.89 Fr and 18.19 Fr at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

0QN1.L Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, June 17, 2026, and so far it has risen 5.67%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Santhera Pharmaceuticals Holding Ag has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Santhera Pharmaceuticals Holding Ag stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at 16.37 Fr. On a fall, the stock will find some support from the short-term average at 15.42 Fr. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Santhera Pharmaceuticals Holding Ag stock

Santhera Pharmaceuticals Holding Ag finds support from accumulated volume at 15.64 Fr and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved 0.180 Fr between high and low, or 1.13%. For the last week, the stock has had daily average volatility of 2.33%.

Our recommended stop-loss: 15.30 Fr (-4.02%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 2 days ago.)

Trading Expectations (0QN1.L) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Santhera Pharmaceuticals Holding Ag to open at 15.97 Fr, and during the day (based on 14 day Average True Range), to move between 15.57 Fr and 16.31 Fr, which gives a possible trading interval of +/-0.738 Fr (+/-4.74%) up or down from last closing price. If Santhera Pharmaceuticals Holding Ag takes out the full calculated possible swing range there will be an estimated 4.74% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at 15.64 Fr (1.88%) than the resistance at 16.50 Fr (3.51%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Santhera Pharmaceuticals Holding Ag stock A Buy?

Santhera Pharmaceuticals Holding Ag holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.356 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on June 22, 2026 - 15.97 Fr ( 0.209%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk